vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and ON24 INC. (ONTF). Click either name above to swap in a different company.

ON24 INC. is the larger business by last-quarter revenue ($34.6M vs $24.7M, roughly 1.4× Editas Medicine, Inc.). ON24 INC. runs the higher net margin — -18.8% vs -22.7%, a 4.0% gap on every dollar of revenue. On growth, ON24 INC. posted the faster year-over-year revenue change (-5.6% vs -19.2%). ON24 INC. produced more free cash flow last quarter ($-2.2M vs $-36.4M). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs -4.2%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

ON24 Inc., a San Francisco-based company, is a cloud-based platform that develops and sells web-based webinar, virtual conferencing, content hub, and landing page applications as a service for marketing and sales teams in B2B organizations. In 2023 it expanded its offerings to include generative AI services.

EDIT vs ONTF — Head-to-Head

Bigger by revenue
ONTF
ONTF
1.4× larger
ONTF
$34.6M
$24.7M
EDIT
Growing faster (revenue YoY)
ONTF
ONTF
+13.6% gap
ONTF
-5.6%
-19.2%
EDIT
Higher net margin
ONTF
ONTF
4.0% more per $
ONTF
-18.8%
-22.7%
EDIT
More free cash flow
ONTF
ONTF
$34.2M more FCF
ONTF
$-2.2M
$-36.4M
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
-4.2%
ONTF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EDIT
EDIT
ONTF
ONTF
Revenue
$24.7M
$34.6M
Net Profit
$-5.6M
$-6.5M
Gross Margin
74.9%
Operating Margin
-31.3%
-23.5%
Net Margin
-22.7%
-18.8%
Revenue YoY
-19.2%
-5.6%
Net Profit YoY
87.6%
26.8%
EPS (diluted)
$0.03
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
ONTF
ONTF
Q4 25
$24.7M
$34.6M
Q3 25
$7.5M
$34.6M
Q2 25
$3.6M
$35.3M
Q1 25
$4.7M
$34.7M
Q4 24
$30.6M
$36.7M
Q3 24
$61.0K
$36.3M
Q2 24
$513.0K
$37.3M
Q1 24
$1.1M
$37.7M
Net Profit
EDIT
EDIT
ONTF
ONTF
Q4 25
$-5.6M
$-6.5M
Q3 25
$-25.1M
$-6.4M
Q2 25
$-53.2M
$-7.3M
Q1 25
$-76.1M
$-8.7M
Q4 24
$-45.4M
$-8.9M
Q3 24
$-62.1M
$-11.4M
Q2 24
$-67.6M
$-11.2M
Q1 24
$-62.0M
$-10.7M
Gross Margin
EDIT
EDIT
ONTF
ONTF
Q4 25
74.9%
Q3 25
74.7%
Q2 25
75.1%
Q1 25
73.8%
Q4 24
74.5%
Q3 24
74.3%
Q2 24
74.5%
Q1 24
74.1%
Operating Margin
EDIT
EDIT
ONTF
ONTF
Q4 25
-31.3%
-23.5%
Q3 25
-325.4%
-23.1%
Q2 25
-1440.6%
-26.0%
Q1 25
-1635.1%
-30.1%
Q4 24
-152.2%
-32.1%
Q3 24
-107649.2%
-36.7%
Q2 24
-14016.2%
-35.0%
Q1 24
-5902.3%
-33.1%
Net Margin
EDIT
EDIT
ONTF
ONTF
Q4 25
-22.7%
-18.8%
Q3 25
-333.0%
-18.4%
Q2 25
-1487.8%
-20.6%
Q1 25
-1633.5%
-25.1%
Q4 24
-148.3%
-24.2%
Q3 24
-101870.5%
-31.4%
Q2 24
-13178.8%
-29.9%
Q1 24
-5458.1%
-28.4%
EPS (diluted)
EDIT
EDIT
ONTF
ONTF
Q4 25
$0.03
$-0.15
Q3 25
$-0.28
$-0.15
Q2 25
$-0.63
$-0.17
Q1 25
$-0.92
$-0.21
Q4 24
$-0.55
$-0.21
Q3 24
$-0.75
$-0.27
Q2 24
$-0.82
$-0.27
Q1 24
$-0.76
$-0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
ONTF
ONTF
Cash + ST InvestmentsLiquidity on hand
$146.6M
$37.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$27.3M
$139.4M
Total Assets
$186.5M
$228.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
ONTF
ONTF
Q4 25
$146.6M
$37.0M
Q3 25
$165.6M
$47.2M
Q2 25
$178.5M
$37.7M
Q1 25
$221.0M
$26.8M
Q4 24
$269.9M
$14.9M
Q3 24
$265.1M
$11.0M
Q2 24
$279.1M
$15.5M
Q1 24
$296.2M
$18.3M
Total Debt
EDIT
EDIT
ONTF
ONTF
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$57.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EDIT
EDIT
ONTF
ONTF
Q4 25
$27.3M
$139.4M
Q3 25
$13.5M
$144.3M
Q2 25
$19.2M
$150.0M
Q1 25
$62.4M
$153.7M
Q4 24
$134.3M
$159.4M
Q3 24
$175.6M
$164.9M
Q2 24
$232.0M
$170.8M
Q1 24
$294.4M
$174.4M
Total Assets
EDIT
EDIT
ONTF
ONTF
Q4 25
$186.5M
$228.4M
Q3 25
$201.8M
$224.8M
Q2 25
$210.6M
$235.1M
Q1 25
$263.7M
$245.8M
Q4 24
$341.6M
$251.0M
Q3 24
$327.6M
$250.9M
Q2 24
$384.8M
$259.0M
Q1 24
$440.3M
$269.2M
Debt / Equity
EDIT
EDIT
ONTF
ONTF
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.43×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
ONTF
ONTF
Operating Cash FlowLast quarter
$-36.4M
$-1.1M
Free Cash FlowOCF − Capex
$-36.4M
$-2.2M
FCF MarginFCF / Revenue
-147.3%
-6.4%
Capex IntensityCapex / Revenue
0.2%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
ONTF
ONTF
Q4 25
$-36.4M
$-1.1M
Q3 25
$-30.8M
$2.5M
Q2 25
$-50.2M
$2.6M
Q1 25
$-47.8M
$3.4M
Q4 24
$-50.8M
$985.0K
Q3 24
$-52.6M
$295.0K
Q2 24
$-57.1M
$1.4M
Q1 24
$-49.9M
$2.1M
Free Cash Flow
EDIT
EDIT
ONTF
ONTF
Q4 25
$-36.4M
$-2.2M
Q3 25
$-31.3M
$2.2M
Q2 25
$2.1M
Q1 25
$-47.9M
$1.9M
Q4 24
$-51.3M
$424.0K
Q3 24
$-55.5M
$143.0K
Q2 24
$-60.6M
$898.0K
Q1 24
$-51.7M
$1.1M
FCF Margin
EDIT
EDIT
ONTF
ONTF
Q4 25
-147.3%
-6.4%
Q3 25
-414.6%
6.2%
Q2 25
5.9%
Q1 25
-1028.6%
5.6%
Q4 24
-167.6%
1.2%
Q3 24
-90998.4%
0.4%
Q2 24
-11804.3%
2.4%
Q1 24
-4558.9%
2.9%
Capex Intensity
EDIT
EDIT
ONTF
ONTF
Q4 25
0.2%
3.3%
Q3 25
5.7%
1.1%
Q2 25
0.0%
1.4%
Q1 25
2.4%
4.2%
Q4 24
1.8%
1.5%
Q3 24
4788.5%
0.4%
Q2 24
681.1%
1.3%
Q1 24
164.8%
2.8%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons